It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

Chronic pain affects approximately 1 in 5 Americans, and yet it remains one of the most misunderstood and challenging medical ...

Swap your mattress and buy well-fitting footwear – these are just two of the small changes experts believe will keep ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...